Henan Taloph Pharmaceutical Stock (600222.SH): The net income for the first three quarters was 28.8959 million yuan, a year-on-year increase of 270.72%.

Gelonghui Finance · Oct 24, 2024 17:59

On October 24, Gelonhui reported that Henan Taloph Pharmaceutical Stock (600222.SH) released its third quarter report for 2024, with the company's revenue for the first three quarters of the year at 1.341 billion yuan, a 7.08% year-on-year decrease; net income attributable to shareholders of the listed company was 28.8959 million yuan, a 270.72% year-on-year increase; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 19.4868 million yuan, a 181.61% year-on-year increase; and the basic earnings per share was 0.0519 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

太龙药业(600222.SH)：前三季度净利润2889.59万元，同比增长270.72%

Henan Taloph Pharmaceutical Stock (600222.SH): The net income for the first three quarters was 28.8959 million yuan, a year-on-year increase of 270.72%.

Risk Disclaimer

Statement